In early June, I met with Penny Pennington Howard, a mother of three, who lives in Carrollton, Texas, about 25 minutes outside of Dallas. Posted in the glass of her front door are two signs you can’t quite make out from the sidewalk: one asking visitors not to smoke, as oxygen treatments are in use; the other a yellow diamond informing guests this is the home of a special needs child. Penny welcomed me inside, out of the glare of the sun, and led me through her living room into her kitchen, where her kids were gathered for lunch. Seth, then eight months old, was plucking cereal off the tray of his highchair, while Lily, seven, was darting back and forth between the countertop and table. Harper, a blond five-year-old with hot pink toenails, was reclining in her “tomato chair,” a molded plastic seat with straps to help keep her steady.
Cannabinoids, terpenoids, and other compounds are secreted by glandular trichomes that occur most abundantly on the floral calyxes and bracts of female plants. As a drug it usually comes in the form of dried flower buds (marijuana), resin (hashish), or various extracts collectively known as hashish oil. In the early 20th century, it became illegal in most of the world to cultivate or possess Cannabis for sale or personal use.
Until recent times, the cultivation of hemp primarily as an oilseed was largely unknown, except in Russia. Today, it is difficult to reconstruct the type of plant that was grown there as an oilseed, because such cultivation has essentially been abandoned. Oilseed hemp cultivars in the modern sense were not available until very recently, but some land races certainly were grown specifically for seeds in Russia. Dewey (1914) gave the following information: “The short oil-seed hemp with slender stems, about 30 inches high, bearing compact clusters of seeds and maturing in 60 to 90 days, is of little value for fiber production, but the experimental plants, grown from seed imported from Russia, indicate that it may be valuable as an oil-seed crop to be harvested and threshed in the same manner as oil-seed flax.” Most hemp oilseed in Europe is currently obtained from so-called “dual usage” plants (employed for harvest of both stem fiber and seeds, from the same plants). Of the European dual-usage cultivars, ‘Uniko B’ and ‘Fasamo’ are particularly suited to being grown as oilseeds. Very recently, cultivars have been bred specifically for oilseed production. These include ‘Finola,’ formerly known as ‘Fin-314’ (Fig. 6) and ‘Anka’ (Fig. 7), which are relatively short, little-branched, mature early in north-temperate regions, and are ideal for high-density planting and harvest with conventional equipment. Dewey (1914) noted that a Turkish narcotic type of land race called “Smyrna” was commonly used in the early 20th century in the US to produce birdseed, because (like most narcotic types of Cannabis) it is densely branched, producing many flowers, hence seeds. While oilseed land races in northern Russia would have been short, early-maturing plants in view of the short growing season, in more southern areas oilseed landraces likely had moderate height, and were spaced more widely to allow abundant branching and seed production to develop. Until Canada replaced China in 1998 as a source of imported seeds for the US, most seeds used for various purposes in the US were sterilized and imported from China. Indeed, China remains the largest producer of hempseed. We have grown Chinese hemp land races, and these were short, branched, adapted to a very long growing season (i.e. they come into flower very slowly in response to photoperiodic induction of short days in the fall), and altogether they were rather reminiscent of Dewey’s description of Smyrna. Although similar in appearance to narcotic strains of C. sativa, the Chinese land races we grew were in fact low in intoxicating constituents, and it may well be that what Dewey thought was a narcotic strain was not. Although some forms of C. sativa have quite large seeds, until recently oilseed forms appear to have been mainly selected for a heavy yield of seeds, usually recognizable by abundant branching. Such forms are typically grown at lower densities than hemp grown only for fiber, as this promotes branching, although it should be understood that the genetic propensity for branching has been selected. Percentage or quality of oil in the seeds does not appear to have been important in the past, although selection for these traits is now being conducted. Most significantly, modern selection is occurring with regard to mechanized harvesting, particularly the ability to grow in high density as single-headed stalks with very short branches bearing considerable seed.
Cannabis sativa is an annual wind-pollinated plant, normally dioecious and dimorphic, although sometimes monoecious (mostly in several modern European fiber cultivars). Figure 2 presents the basic morphology of the species. Some special hybrids, obtained by pollinating females of dioecious lines with pollen from monoecious plants, are predominantly female (so-called “all-female,” these generally also produce some hermaphrodites and occasional males). All-female lines are productive for some purposes (e.g. they are very uniform, and with very few males to take up space they can produce considerable grain), but the hybrid seed is expensive to produce. Staminate or “male” plants tend to be 10%–15% taller and are less robust than the pistillate or “female” (note the comparatively frail male in Fig. 3). So prolific is pollen production that an isolation distance of about 5 km is usually recommended for generating pure-bred foundation seed. A “perigonal bract” subtends each female flower, and grows to envelop the fruit. While small, secretory, resin-producing glands occur on the epidermis of most of the above-ground parts of the plant, the glands are very dense and productive on the perigonal bracts, which are accordingly of central interest in marijuana varieties. The root is a laterally branched taproot, generally 30–60 cm deep, up to 2.5 m in loose soils, very near the surface and more branched in wet soils. Extensive root systems are key to the ability of hemp crops to exploit deep supplies of nutrients and water. The stems are erect, furrowed, and usually branched, with a woody interior, and may be hollow in the internodes. Although the stem is often woody, the species is frequently referred to as a herb or forb. Plants vary enormously in height depending on genetic constitution and environment (Fig. 4), but are typically 1–5 m (heights of 12 m or more in cultivation have been claimed).
Despite its designation as having no medicinal use, Cannabis was distributed by the U.S. government to patients on a case-by-case basis under the Compassionate Use Investigational New Drug program established in 1978. Distribution of Cannabis through this program was closed to new patients in 1992.[1-4] Although federal law prohibits the use of Cannabis, Figure 1 below shows the states and territories that have legalized Cannabis use for medical purposes. Additional states have legalized only one ingredient in Cannabis, such as cannabidiol (CBD), and are not included in the map. Some medical marijuana laws are broader than others, and there is state-to-state variation in the types of medical conditions for which treatment is allowed.
Scientists in Europe and North America concluded that hemp seed is an excellent source of nutrition. Numerous anecdotal incidences cited improvements in a wide range of acute and chronic conditions such as rapid healing of skin lesions and relief from flu, inflammation, and allergies. The benefits were attributed to the presence of rich source of the EFAs linoleic and alpha-linolenic acid, and their respective biologic metabolites, GLA and stearidonic acid.9
Toggle navigationNewsConditionsConditionsADHDAllergic rhinitisAlzheimer's diseaseAnxietyArthritisAsthmaAutismBowel cancerBreast cancerCancerChesty coughsChickenpoxChlamydiaCholesterolCoeliac diseaseCommon coldConstipationCOPDDepressionDiabetesDiverticulitisEpilepsyFatty liverFibromyalgiaGenital herpesGORD (reflux)GoutHaemorrhoidsHair lossHeart attackHepatitisHiatus herniaHigh blood pressureHIV and AIDSImpotenceMenopauseMigraineNeuropathic painOsteoporosisPainPeptic ulcersPneumoniaProstate cancerScabiesSchizophreniaSciaticaShinglesSinusitisSkin cancerStrokeThyroid gland disordersUrticaria (hives)Vaginal thrushVasectomyVertigoVulval problemsWhooping coughMedicinesMedicinesAugmentinAvilChlorsigDaklinzaDuromineEndepEndoneHarvoniLevlenLyricaMersyndolMetrogylPanadeine FortePanefcortelonePrimolutRestavitSovaldiStemetilViagraZentelFind a MedicineMedicines CentreSymptomsSymptomsBack painChildhood rashesCommon coldDepressionFeverFibromyalgiaHeart attackHeel painHerpesLeg acheLeg crampsSciaticaShinglesStrokeVaginal thrushVertigoMore symptomsLifestyleHealthy LifestyleAddictionsAlcoholCholesterolExerciseHealthy eatingHealthy WeightHeart healthImmunisationSleepSmokingStress Health Centres Nutrition & WeightSports & FitnessTools Medical Dictionary Medical Dictionary
Everything you need to know about marijuana (cannabis) Marijuana, or cannabis, is the most commonly used illicit drug in the world. It alters the mood and affects nearly every organ in the body. With at least 120 active compounds, marijuana may have health benefits as well as risks. We describe these, addiction, and withdrawal. Learn more about cannabis here. Read now
It sounds like the title of a children’s book, but like so much else that you learned in kindergarten, it’s true. Everyone’s body is different – but everyone’s endocannabinoid system is really unique. For reasons we don’t fully understand, receptors in the endocannabinoid system don’t respond predictably to cannabinoids from person to person. This lack of a predictable response makes standard dosing tricky.
Reproduced with kind permission from the Australian Drug Foundation. References Australian Drug Foundation. Cannabis Facts. Last updated 25 Jan 2012. http://www.druginfo.adf.org.au/drug-facts/cannabis (accessed Jan 2013). Australian Drug Foundation (ADF) Vision: Healthy People, Strong Communities. Mission: Working together to prevent alcohol and other drug problems in communities.Related ArticlesCannabis psychosisUse of cannabis can cause a condition called drug-induced psychosis. Cannabis useCannabis can affect your physical and mental health with heavy cannabis use potentially causing psycCannabis: tolerance and dependenceAfter prolonged use, cannabis is addictive and people using cannabis regularly develop dependence anCannabis: withdrawal and treatmentIf a dependent person stops taking cannabis, they may experience withdrawal symptoms. Cannabis/marijuana: what are the effects?The effect of cannabis on a person depends on many factors including their size, weight and health aAdvertisement
Despite advanced analytical techniques, much of the cannabis used recreationally is inaccurately classified. One laboratory at the University of British Columbia found that Jamaican Lamb’s Bread, claimed to be 100% sativa, was in fact almost 100% indica (the opposite strain). Legalization of cannabis in Canada (as of October 17, 2018) may help spur private-sector research, especially in terms of diversification of strains. It should also improve classification accuracy for cannabis used recreationally. Legalization coupled with Canadian government (Health Canada) oversight of production and labelling will likely result in more -- and more accurate -- testing to determine exact strains and content. Furthermore, the rise of craft cannabis growers in Canada should ensure quality, experimentation/research, and diversification of strains among private-sector producers.
Scott Shannon, M.D., assistant clinical professor at the University of Colorado, recently sifted through patient charts from his four-doctor practice to document CBD’s effects on anxiety. His study, as yet unpublished, found “a fairly rapid decrease in anxiety scores that appears to persist for months,” he says. But he says he can’t discount a placebo effect, especially since “there’s a lot of hype right now.”
I’ve done a little research on the hemp and cannabis, and it looks to me like they’re both supposed to be medicine plants. From what I learned about the plants, they’ve been known to actually have multiple health benefits and even save lives of fourth stage cancer patients, sending the cancer into remission and therefore saving the patient lives. Banning this medicine plant has actually caused the deaths of many people who could have otherwise been saved by this plant. No wonder people are getting it other ways, I don’t blame them as long as it’s strictly for medical purposes. I even heard of a case where one child’s seizures were so bad they had to end up moving to Colorado as a last resort to save that little girl’s life by giving her cannabis because no other medicine worked for her.
Selective breeding of cannabis plants has expanded and diversified as commercial and therapeutic markets develop. Some growers in the U.S. succeeded in lowering the proportion of CBD-to-THC to accommodate customers who preferred varietals that were more mind-altering due to the higher THC and lower CBD content. Hemp is classified as any part of the cannabis plant containing no more than 0.3% THC in dry weight form (not liquid or extracted form).
Out of the 17 states that have passed CBD-only laws, five— Missouri, Florida, Mississippi, Louisiana, and Texas—would also establish licensed cultivation centers to grow high-CBD strains of cannabis, which could be turned into oils and other CBD products. This would cut down on the demand for CBD oil from unregulated manufacturers abroad. Even then, though, impediments remain. In Missouri, for example, two neurologists recently refused to prescribe CBD oil for an eight- year-old boy suffering from seizures, citing concerns over federal law and the safety of non-FDA approved products.
Without arguing the merits of the above contentions, we point out that the legitimate use of hemp for non-intoxicant purposes has been inhibited by the continuing ferocious war against drug abuse. In this atmosphere, objective analysis has often been lacking. Unfortunately both proponents and opponents have tended to engage in exaggeration. Increasingly, however, the world is testing the potential of hemp in the field and marketplace, which surely must be the ultimate arbiters. De Guzman (2001), noting the pessimistic USDA report, observed that “Nevertheless, others point to the potential of [the] market. Hemp products have a growing niche market of their own, and the market will remain healthy and be well supported with many competing brands.”
With a hypothesis that chronic marijuana use produces adverse effects on the human endocrine and reproductive systems, the association between Cannabis use and incidence of testicular germ cell tumors (TGCTs) has been examined.[12-14] Three population-based case-control studies reported an association between Cannabis use and elevated risk of TGCTs, especially nonseminoma or mixed-histology tumors.[12-14] However, the sample sizes in these studies were inadequate to address Cannabis dose by addressing associations with respect to recency, frequency, and duration of use. In a study of 49,343 Swedish men aged 19 to 21 years enrolled in the military between 1969 and 1970, participants were asked once at the time of conscription about their use of Cannabis and were followed up for 42 years. This study found no evidence of a significant relation between “ever” Cannabis use and the development of testicular cancer, but did find that “heavy” Cannabis use (more than 50 times in a lifetime) was associated with a 2.5-fold increased risk. Limitations of the study were that it relied on indirect assessment of Cannabis use; and no information was collected on Cannabis use after the conscription-assessment period or on whether the testicular cancers were seminoma or nonseminoma subtypes. These reports established the need for larger, well-powered, prospective studies, especially studies evaluating the role of endocannabinoid signaling and cannabinoid receptors in TGCTs.
Nevertheless, every bit of this ancient plant is useful and valuable, and not just for rope, but for textiles, auto parts, cosmetics, dynamite, supplements, food, and medicine. In ancient China, hemp seed was regarded as food for the lower classes, and in Europe, a peanut butter-like spread was made from the seeds, in both cases with the hulls intact.
In Canada, the methodology used for analyses and sample collection for THC analysis of hemp plantings is standardized (at the Health Canada/Therapeutics Program/Hemp web site at www.hc-sc.gc.ca/hpb-dgps/therapeut/htmleng/hemp.html, see “Industrial Hemp Technical Manual” for procedures on sampling plant materials and chemical procedures for determining THC levels). The regulations require that one of the dozen independent laboratories licensed for the purpose conduct the analyses and report the results to Health Canada. Sample collection is also normally carried out by an independent authorized firm. The Canadian system of monitoring THC content has rigidly limited hemp cultivation to cultivars that consistently develop THC levels below 0.3%.
The arrival of Epidiolex is unlikely to erase the unregulated CBD market, however. For one, Epidiolex has been studied only in connection with a small number of epileptic conditions. If and when Epidiolex makes its way to drug stores, it will be approved only for the treatment of Dravet Syndrome and Lennox-Gastaut Syndrome, two rare forms of catastrophic epilepsy. People like me, with comparatively mild Janz Syndrome, and people like Harper, with extremely rare conditions like CDKL5, may still be out of luck.
The downsides of graphene are its dwindling sources and costly process to mine and import from rural areas in China and India. Hemp, however, can be grown in almost any terrain or country, and produces hemp bast, the key material used to replace graphene, as a waste byproduct of hemp processing. According to Mitlin’s research, hemp processing is 1,000 times cheaper than graphene processing.
California Food and Agricultural Code (FAC) Section 81001 establishes an Industrial Hemp Advisory Board to advise CDFA and make recommendations pertaining to the cultivation of industrial hemp, including industrial hemp seed law and regulations, annual budgets, and the setting of an assessment rate. FAC Section 81001 also outlines the membership and administration of the Board.
Breeding for low THC cultivars in Europe has been reviewed by Bócsa (1998), Bócsa and Karus (1998), and Virovets (1996). Some researchers have claimed to have produced essentially THC-free strains, although at present no commercial cultivar seems to be 100% free of THC. THC content has proven to be more easily reduced in monoecious than in dioecious varieties. It should be possible to select THC-free strains, and there has been speculation that genetic engineering could be helpful in this regard. As a strategic economic and political tactic, France has been attempting for several years to have the European Union (EU) adopt legislation forbidding the cultivation of industrial hemp cultivars with more than 0.1% THC, which would mean that primarily French varieties would have to be cultivated in Europe. However, the Canadian government has found that some French material has proven to be excessively high in THC.
In recent decades, the neurobiology of cannabinoids has been analyzed.[12-15] The first cannabinoid receptor, CB1, was identified in the brain in 1988. A second cannabinoid receptor, CB2, was identified in 1993. The highest expression of CB2 receptors is located on B lymphocytes and natural killer cells, suggesting a possible role in immunity. Endogenous cannabinoids (endocannabinoids) have been identified and appear to have a role in pain modulation, control of movement, feeding behavior, mood, bone growth, inflammation, neuroprotection, and memory.